Digestive & Liver Disease journal published an article on Low Molecular Weight Heparin MMX

05/10/2007

Digestive & Liver Disease, a journal of the Elsevier Group, in its September 2007 issue, published the article: Safety and Efficacy of Oral, Colonic-Release low molecular weight Heparin MMX™ for the treatment of mild to moderate left sided Ulcerative Colitis: a preliminary report for a pilot study.

 

 

Contacts
For further information, please contact:
Dr. Chris Tanner, CFO
Cosmo Pharmaceuticals
Via C. Colombo 1 1 - 20020 Lainate, Italy
Tel: +39 02 9333 7614




Adobe Reader icon and link to Adobe website (opens in a new window) This page includes links to documents in Portable Document File (PDF) format. To read PDF documents you may need to download the free Adobe Reader. For PDF accessibility help, visit Access Adobe. These links will open in a new browser window.


Back to top